Literature DB >> 9422736

Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral.

M Ikeda1, O Ishida, T Hinoi, S Kishida, A Kikuchi.   

Abstract

Ral-binding protein 1 (RalBP1) is a putative effector protein of Ral and exhibits a GTPase activating activity for Rac and CDC42. To clarify the function of RalBP1, we isolated a novel protein that interacts with RalBP1 by yeast two-hybrid screening and designated it POB1 (partner of RalBP1). POB1 consists of 521 amino acids, shares a homology with Eps15, which has been identified as an epidermal growth factor (EGF) receptor substrate, and has two proline-rich motifs. The POB1 mRNA was expressed in cerebrum, cerebellum, lung, kidney, and testis. POB1 interacted with RalBP1 in COS cells and the C-terminal region of POB1 was responsible for this interaction. The binding domain of RalBP1 to POB1 was distinct from its binding domain to Ral. Ral and POB1 simultaneously interacted with RalBP1 in COS cells. The binding of POB1 to RalBP1 did not affect the GTPase activating activity of RalBP1. Furthermore, POB1 bound to Grb2 but not to Nck or Crk. POB1 was tyrosine-phosphorylated in COS cells upon stimulation with EGF and made a complex with EGF receptor. These results suggest that RalBP1 makes a complex with POB1 and that this complex may provide a link between tyrosine kinase, Src homology 3 (SH3)-containing protein, and Ral.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422736     DOI: 10.1074/jbc.273.2.814

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.

Authors:  T Goi; G Rusanescu; T Urano; L A Feig
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 2.  Role of RLIP76 in doxorubicin resistance in lung cancer.

Authors:  Rit Vatsyayan; Pankaj Chaudhary; Poorna Chandra Rao Lelsani; Preeti Singhal; Yogesh C Awasthi; Sanjay Awasthi; Sharad S Singhal
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

3.  M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex.

Authors:  Koji Hase; Shunsuke Kimura; Hiroyuki Takatsu; Masumi Ohmae; Sayaka Kawano; Hiroshi Kitamura; Masatoshi Ito; Hiroshi Watarai; C Clayton Hazelett; Charles Yeaman; Hiroshi Ohno
Journal:  Nat Cell Biol       Date:  2009-11-22       Impact factor: 28.824

Review 4.  All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral.

Authors:  J L Bos
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

5.  Enhancement of endocytic uptake of HIV-1 virions into CD4-negative epithelial cells by HIV-1 gp41 via its interaction with POB1.

Authors:  Yue Tan; Junyi Wang; Shan Su; Qian Wang; Shibo Jiang; Lu Lu; Ying-Hua Chen
Journal:  Cell Mol Immunol       Date:  2015-05-25       Impact factor: 11.530

6.  KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2.

Authors:  L Jia; Z Zhou; H Liang; J Wu; P Shi; F Li; Z Wang; C Wang; W Chen; H Zhang; Y Wang; R Liu; J Feng; C Chen
Journal:  Oncogene       Date:  2015-07-20       Impact factor: 9.867

7.  Glutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.

Authors:  Humberto Rodriguez-Rocha; Aracely Garcia Garcia; Laura Zavala-Flores; Sumin Li; Nandakumar Madayiputhiya; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-09-14       Impact factor: 8.401

8.  RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization.

Authors:  Seunghyung Lee; Jeremy G T Wurtzel; Sharad S Singhal; Sanjay Awasthi; Lawrence E Goldfinger
Journal:  Cancer Res       Date:  2012-08-17       Impact factor: 12.701

Review 9.  RLIP76: A novel glutathione-conjugate and multi-drug transporter.

Authors:  Sharad S Singhal; Sushma Yadav; Cherice Roth; Jyotsana Singhal
Journal:  Biochem Pharmacol       Date:  2008-10-15       Impact factor: 5.858

10.  Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTD.

Authors:  Kihoon Han; Myoung-Hwan Kim; Daniel Seeburg; Jinsoo Seo; Chiara Verpelli; Seungnam Han; Hye Sun Chung; Jaewon Ko; Hyun Woo Lee; Karam Kim; Won Do Heo; Tobias Meyer; Hyun Kim; Carlo Sala; Se-Young Choi; Morgan Sheng; Eunjoon Kim
Journal:  PLoS Biol       Date:  2009-09-08       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.